Final kidney disease
Conditions
Interventions
Experimental group:RIPC treatment and routine hemodialysis were given
Control group:Routine hemodialysis
Sponsors
Changzhou Second People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with end-stage renal disease; 2. Aged >= 18 years; 3. Regular dialysis for not less than 3 months, 3 times a week, 4 hours each time; 4. The total incidence of IDH in 3 months before intervention; 5. Dry weight with weight gain <= 5% during dialysis ; 6. Body fluid clearance rate (%) = (pre-dialysis weight-post-dialysis weight) / post-dialysis weight * 100%); 7. Arteriovenous fistula dialysis; 8. Stable condition; 9. Those who voluntarily participate in the test and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Autar Deep Venous Thrombosis risk Assessment scale score >= 7; 2. Revised Braden scale = 160/110mmHg). 5. Uncontrolled infection and unexplained fever and vasculitis, Raynaud's disease, diabetic foot, capillary fragility, polyneuropathy; 6. Coagulation dysfunction or active visceral effusion; 7. Disturbance of consciousness, patients with mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure;heart rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| TNI;CK-MB; | — |
Countries
China
Contacts
Public ContactLiu Tongqiang
Changzhou Second People's Hospital
Outcome results
None listed